Cargando…
1139. Oral Antivirals Against SARS-CoV-2: a New Valid Strategy Against COVID-19
BACKGROUND: Since the outbreak of COVID-19 pandemic the scientific community efforts have been focused on finding a vaccine and a treatment for infected people. Several antivirals with activity against SARS-CoV-2 were investigated and since the end of 2021 orally administered antivirals have been us...
Autores principales: | Braccialarghe, Neva, Cavasio, Rosario Alessandro, Zaçe, Drieda, Spalliera, Ilaria, Coppola, Luigi, Marco, Iannetta, Sarmati, Loredana, Andreoni, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752135/ http://dx.doi.org/10.1093/ofid/ofac492.977 |
Ejemplares similares
-
280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination
por: Cavasio, Rosario Alessandro, et al.
Publicado: (2022) -
Human Arboviral Infections in Italy: Past, Current, and Future Challenges
por: Rossi, Benedetta, et al.
Publicado: (2023) -
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study
por: Campogiani, Laura, et al.
Publicado: (2023) -
Increased Mild Vaccine-Related Side Effects and Higher Specific Antibody Titers in Health Care Workers with Previous SARS-CoV-2 Infection after the mRNA BNT162b2 Vaccine
por: Ferrari, Ludovica, et al.
Publicado: (2022) -
1970. SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine
por: Marco, Iannetta, et al.
Publicado: (2022)